Pollutants are drivers of chronic disease.
Biotech can stop this.

We're turning decades of research into real interventions that protect people from the long-term effect of exposure to pollutants.

Exposure to pollutants contributes to today's chronic disease burden, costing millions of lives and trillions of dollars in healthcare spending. The damage has been documented. Reversing it requires a new approach.

Four shifts towards engineering human resilience

1
From
Toxicity
Assessment
To
Target
Discovery
Bench
From: Toxicity Assessment
Classical toxicology generates data for regulators, only cataloging harm.
To: Target Discovery
Harness molecular tox data to discover viable targets and treatments.
2
From
Disease
Treatment
To
Early
Intervention
Translation
From: Disease Treatment
Treatments are used once the disease manifests and much damage is done.
To: Early Intervention
Intervening before disease onset and helping individuals reach their full potential.
3
From
Reactive
Regulations
To
Proactive
Incentives
Policy
From: Reactive Regulations
Environmental policy focuses on cleanup and pollution standards.
To: Proactive Incentives
Create regulatory incentives for interventions that build resilience against pollutants.
4
From
Crisis
Response
To
Engineered
Resilience
Defense
From: Crisis Response
Defense stockpiles are mostly for acute threats and ignore chronic chemical burdens.
To: Engineered Resilience
Build defense systems that counteract long-term low exposures to pollutants.
Rotation One

At the Lab Bench

From regulatory endpoints to therapeutic targets. We're transforming how toxicology generates actionable molecular insights.

Rotation Two

Clinical Translation

Catch cellular damage before disease takes hold. Building the diagnostic and therapeutic pipeline that doesn't exist.

Rotation Three

Policy Reforms

Moving policy beyond damage control. Creating incentives for solutions, not just risk assessment.

Rotation Four

Defense Against Pollutants

Expand chemical defense from acute crises to chronic exposures. Developing biological countermeasures for tomorrow's challenges.

Join the movement

Biotech tools exist that could be deployed tomorrow. What's missing is coordination. If you're a researcher, entrepreneur, or funder seeking this alignment, let's talk.

For Funders For Doers

There's more to come

Subscribe to Substack for progress updates and the latest biotech breakthroughs, clinical developments, policy changes, and defense applications towards engineered resilience.

Check your email to confirm your subscription.

The Path Forward

The Evidence Already Exists

Decades of human studies link pollutants to chronic illnesses. We have the data on the problem, now we need the data on how to best intervene.

Exposures Diseases
Air Pollution
Pesticides
PFAS Chemicals
Plasticizers
Heavy Metals
Cancer
Neurological
Cardiovascular
Metabolic
Autoimmune
Neurodevelopmental
Line thickness indicates number of studies. Hover for details.

(full analysis coming soon)

We Could Act Now

Developing early interventions would prevent disease before it starts, would save billions in healthcare costs, and build in accountability for polluters.

Toggle scenarios to explore how savings scale over time Conservative Baseline Optimistic $0 $1T $2T $3T 5yr 10yr 15yr 20yr Avoided Healthcare Costs Research Investment Polluter Liability

(full analysis coming soon)

A Blindspot in the Budget

Roughly 3% of major federal agency grants go towards studies of how pollutants negatively impact human health. Legacy priorities have left a significant funding gap that must be filled.

NIH $167B
EPA $98B
NSF $19B
All Other Research
Env Monitoring of Pollutants
Human Studies on Pollutants

Source: NIH RePORTER, NSF Award Search, USAspending.gov

(full analysis coming soon)